EligibleTrials

Pancreatic Cancer Screening Using the Enzeavour Assay in Japan

Recruiting · NCT07605819 · Interventional (participants receive a specific treatment) · Lead sponsor: Cosomil, Inc.

View the official record on ClinicalTrials.gov →
Pancreatic Cancer

Interventions studied

Enzeavour Pancreatic Cancer Assay

What this trial is about

This nationwide, multicenter, prospective, single-arm interventional feasibility study evaluates the Enzeavour Pancreatic Cancer assay in routine health checkups and cancer screening in Japan. Approximately 10,000 asymptomatic adults will be enrolled. Participants with an Enzeavour Score above 0.369 will undergo diagnostic work-up as clinically indicated. The primary outcome is pancreatic cancer detection rate within 12 months after the index blood draw, and the secondary outcome is positive predictive value.

Who can take part

Age range
20 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

48 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.